About 200 reports

  • Aesica Pharmaceuticals Ltd, Subsidiaries
  • Aesica Pharmaceuticals Ltd, Other Locations

Aesica Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Pharmaceutical
  • United Kingdom
  • Company
  • Supply
  • Aesica Holdco Limited

GlobalData Immunocore Ltd' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • Immunocore Limited
  • SMITH & NEPHEW PLC, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

Summary Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for use in orthopaedic reconstruction and trauma, sports medicines and advanced wound management.The company offers its products in various categories including Sports Medicine Joint Repair,...

  • Healthcare
  • Pharmaceutical
  • Wound Care
  • United Kingdom
  • Company

GlobalData Horizon Discovery Group Plc reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Cell Therapy
  • Pharmaceutical
  • United Kingdom
  • Company
  • Horizon Discovery
  • Circassia Pharmaceuticals Plc, Subsidiaries
  • Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma.The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease. The company had...

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Circassia Pharmaceuticals plc
  • Redx Pharma Plc, Subsidiaries
  • Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics.The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza and hepatitis B. Its...

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Redx Pharma Ltd
  • Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Alliance Pharma Plc, Key Employees

Summary Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company.It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women’s...

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • M&A
  • EUSA Pharma (UK) Ltd, Subsidiaries
  • EUSA Pharma (UK) Ltd - Key Competitors

Summary EUSA Pharma (UK) Ltd (EUSA), formerly Essex Bidco is a pharmaceutical company that delivers medical treatment to improve patients’ lives.The company’s product portfolio focuses on areasOncology, Oncologysupportive care, Surgery and emergency solutions and Neurology. The company’s products comprise caphosol,...

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • EUSA Pharma Inc.
  • VIIV HEALTHCARE LTD, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2011 TO YTD 2017
  • VIIV HEALTHCARE ANNOUNCES LICENSING AGREEMENT FOR CELSENTRI

Summary ViiV Healthcare Ltd (ViiV), formerly Glaxosmithkline Newco Ltd, a subsidiary of GlaxoSmithKline Plc, is a researcher and developer of HIV medicines. The company provides nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitor, protease inhibitors, and CCR5 antagonist for the treatment of...

  • Antiviral
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Britannia Pharmaceuticals Ltd, History
  • Britannia Pharmaceuticals Ltd - Key Employees

Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Pharmaceutical
  • Psychotic Disorder
  • United Kingdom
  • Company
  • Britannia Pharmaceuticals Ltd.

GlobalData NightstaRx Ltd' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • Sisaf Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • SISAF RAISES USD3.5 MILLION IN SERIES A FINANCING

Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications.The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSillic-RX, for gene...

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company

The company offers Flow Mk-## and Flow Mk-## products.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Cambridge Enterprise Limited

GlobalData Monopar Therapeutics Inc' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to four pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • Monopar
  • Bicycle Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases.The company’s proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to identify bicycles that provide...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • Evotec AG, Key Competitors
  • Evotec Enters Into Co-Development Agreement With Probiodrug For Glutaminyl Cyclase

Earlier, on October ##, 2012, Bayer Pharma entered into five-year, multi-target agreement with Evotec.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Evotec AG
  • Deal Type

The company' s deal volume increased from one pharmaceuticals & healthcare deal in 2016 to three pharmaceuticals & healthcare deals in 2017.

  • Biopharmaceutical
  • Pharmaceutical
  • United Kingdom
  • Company
  • Mereo Biopharma Group Limited

GlobalData Deal Type Venture Financing Acquisition Licensing Agreement Partnerships No. of Deals ## ## ## ## Deal Value (US$ million) ##. ## NA NA NA Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Cell Medica Ltd, Pharmaceuticals

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Cell Medica Limited

GlobalData Reckitt Benckiser Group Plc' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Reckitt Benckiser Group plc

GlobalData Monopar Therapeutics Inc' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to four pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • Monopar

TCB was one of only ## projects selected out of ## applications from the June cut-off.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • TC BioPharm Ltd.

GlobalData Centauri Therapeutics Ltd' s, deal volume decreased from four pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • UCL Business PLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations.The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the transfer into industry of expertise...

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • UCL Business PLC

The company' s deal volume decreased from four pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • BioInvent
  • HVIVO PLC, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018
  • HVIVO RAISES USD31 MILLION IN PRIVATE PLACEMENT OF SHARES

Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human disease model platform...

  • Influenza
  • Pharmaceutical
  • United Kingdom
  • Company
  • hVIVO plc
  • Ergomed Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Ergomed Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd is a drug development and clinical research services provider.The company provides service portfolio such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and others. It also provides...

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Ergomed plc

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • IXICO plc
  • Deal Type
  • Deal Type

GlobalData Deal Type Equity Offerings Licensing Agreement Partnerships No. of Deals ## ## ## Deal Value (US$ million) ##. ## NA NA OXFORD PHARMASCIENCE GROUP PLC, PHARMACEUTICALS & HEALTHCARE, DEALS BY REGION, 2012 TO YTD 2018 Oxford Pharmascience Group Plc,

  • Analgesic
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Licensee Company Information Licensee Name
  • Licensee Company Information Licensee Name

N+## Singer Limited acted as nominated advisor and broker to Futura Medical for the transaction.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Futura Medical plc
  • Deal Rationale
  • SCANCELL RAISES USD4 MILLION IN RIGHTS OFFERING OF SHARES

GlobalData Region Europe North America Asia-Pacific Middle East and Africa South and Central America No. of Deals ## ## ## ## ## Deal Value (US$ million) ##. ## NA NA NA NA Scancell Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Company
  • Scancell Holdings Plc